Saba Ilac Sanayive Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SABA ILAC SANAYIVE
SABA ILAC SANAYIVE has two approved drugs.
Drugs and US Patents for Saba Ilac Sanayive
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saba Ilac Sanayive | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217934-001 | Jul 1, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Saba Ilac Sanayive | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 215856-001 | Apr 2, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

